Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-15 7:20 pm Unchanged | 2024-10-10 | 13D | iTeos Therapeutics, Inc. ITOS | Boxer Asset Management Inc. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-09-30 09:00 am Purchase | 2024-09-26 | 13G | iTeos Therapeutics, Inc. ITOS | TANG CAPITAL MANAGEMENT, LLC | 2,407,800 6.600% | 2,407,800 (New Position) | Filing History |
| 2024-05-15 08:37 am Purchase | 2024-05-10 | 13D | iTeos Therapeutics, Inc. ITOS | Boxer Capital LLC | 2,946,915 8.100% | 792,857 (+36.81%) | Filing History |
| 2024-05-14 9:10 pm Sale | 2024-05-10 | 13D | iTeos Therapeutics, Inc. ITOS | RA CAPITAL MANAGEMENT L.P. | 3,659,046 9.990% | -758,213 (-17.16%) | Filing History |
| 2024-02-16 12:54 pm Purchase | 2024-02-05 | 13G | iTeos Therapeutics, Inc. ITOS | EcoR1 Capital, LLC | 1,944,672 5.400% | 1,944,672 (New Position) | Filing History |
| 2024-02-14 09:45 am Sale | 2023-12-31 | 13G | iTeos Therapeutics, Inc. ITOS | BIOTECHNOLOGY VALUE FUND L P | 1,259,476 3.500% | -551,359 (-30.45%) | Filing History |
| 2024-02-13 5:08 pm Sale | 2023-12-29 | 13G | iTeos Therapeutics, Inc. ITOS | The Vanguard Group | 1,490,942 4.170% | -328,088 (-18.04%) | Filing History |
| 2024-01-23 4:13 pm Sale | 2023-12-31 | 13G | iTeos Therapeutics, Inc. ITOS | BlackRock Inc. BLK | 4,261,745 11.900% | -217,676 (-4.86%) | Filing History |
| 2024-01-09 4:26 pm Sale | 2023-12-31 | 13G | iTeos Therapeutics, Inc. ITOS | Millennium Management LLC | 967,402 2.700% | -1,123,431 (-53.73%) | Filing History |
| 2023-10-24 4:12 pm Purchase | 2023-10-17 | 13G | iTeos Therapeutics, Inc. ITOS | Millennium Management LLC | 2,090,833 5.800% | 2,090,833 (New Position) | Filing History |
| 2023-02-14 10:08 am Sale | 2022-12-31 | 13G | iTeos Therapeutics, Inc. ITOS | RTW Investments, LP | 0 0.000% | -2,353,015 (Position Closed) | Filing History |
| 2023-02-13 6:14 pm Sale | 2022-12-31 | 13G | iTeos Therapeutics, Inc. ITOS | BIOTECHNOLOGY VALUE FUND L P | 1,810,835 5.100% | -118,366 (-6.14%) | Filing History |
| 2023-02-09 11:22 am Purchase | 2022-12-30 | 13G | iTeos Therapeutics, Inc. ITOS | The Vanguard Group | 1,819,030 5.110% | 1,819,030 (New Position) | Filing History |
| 2023-01-26 08:52 am Unchanged | 2022-12-31 | 13G | iTeos Therapeutics, Inc. ITOS | BlackRock Inc. BLK | 4,479,421 12.600% | 0 (Unchanged) | Filing History |
| 2023-01-20 5:17 pm Purchase | 2022-12-31 | 13G | iTeos Therapeutics, Inc. ITOS | BlackRock Inc. BLK | 4,479,421 12.600% | 758,184 (+20.37%) | Filing History |
| 2022-07-08 4:56 pm Purchase | 2022-06-30 | 13G | iTeos Therapeutics, Inc. ITOS | BlackRock Inc. BLK | 3,721,237 10.500% | 3,721,237 (New Position) | Filing History |
| 2022-05-11 5:14 pm Sale | 2022-05-09 | 13D | iTeos Therapeutics, Inc. ITOS | Boxer Capital LLC | 2,154,058 6.100% | -988,000 (-31.44%) | Filing History |
| 2022-05-02 5:02 pm Purchase | 2022-04-22 | 13G | iTeos Therapeutics, Inc. ITOS | BIOTECHNOLOGY VALUE FUND L P | 1,929,201 5.400% | 1,929,201 (New Position) | Filing History |
| 2022-03-18 9:00 pm Sale | 2022-03-17 | 13D | iTeos Therapeutics, Inc. ITOS | Boxer Capital LLC | 3,142,058 8.900% | -575,201 (-15.47%) | Filing History |
| 2022-02-14 08:41 am Sale | 2021-12-31 | 13G | iTeos Therapeutics, Inc. ITOS | RTW Investments, LP | 2,353,015 6.700% | -409,776 (-14.83%) | Filing History |